Association between skin manifestations and glycemic control in patients with type 2 diabetes mellitus
Abstract
Background/Aim. Diabetes mellitus (DM) can be associated with numerous skin diseases. This study aimed to determine the pattern and incidence of skin manifestations in patients with type 2 DM and their link to glycemic control. Methods. This cross-sectional study was conducted at the Skin and Venereal Diseases Clinic, University Clinical Centre of the Republic of Srpska in Banja Luka, Bosnia and Herzegovina, from January 2016 to January 2018. Adult patients of both genders suffering from type 2 DM and cutaneous manifestations participated in the study. Glycemic control was assessed according to the values of glycated hemoglobin (HbA1c) of 7%. Results. The mean age of 105 study participants (46% male and 54% female) was 68.4 ± 10 years, while the mean HbA1c was 8.3 ± 1.6%. Unsatisfactory glycemic control was found in 74.3% of patients with the mean HbA1c at 8.9 ± 1.4%, while satisfactory glycemic control was found in 25.7% of patients, with the mean HbA1c at 6.7 ± 0.2% (p < 0.001). Infections were the most frequent skin diseases (43.9%). Bacterial infections were most common (26.7%), followed by fungal infections (24.8%), xerosis (17.1%), psoriasis (15.2%), fibroma molle (14.3%), diabetic ulcer (7.7%), prurigo (6.7%), and stasis dermatitis (5.7%). Other skin manifestations were found at a lower rate. A significant association was found between unsatisfactory glycemic control and skin infections (p = 0.009). Conclusion. The most common skin manifestations in patients with type 2 diabetes are infections. They occurred more often in patients with unsatisfactory glycemic control.
References
Farshchian M, Farshchian M, Fereydoonnejad M, Yazdanfar A, Kimyai-Asadi A. Cutaneous manifestations of diabetes melli-tus: a case series. Cutis 2010; 86(1): 31‒5.
Lima AL, Illing T, Schliemann S, Elsner P. Cutane-ous Manifestations of Diabetes Mellitus: A Review. Am J Clin Dermatol 2017; 18(4): 541‒53.
De Macedo GMC, Nunes S, Barreto T. Skin disorders in diabetes mellitus: an epidemiology and physiopathology review. Diabe-tol Metab Syndr 2016; 8: 63.
Goyal A, Raina S, Kaushal SS, Mahajan V, Sharma NL. Pat-tern of cutaneous manifestations in diabetes mellitus. Indian J Dermatol 2010; 55(1): 39-41.
Duff M, Demidova O, Blackburn S, Jay Shubrook J. Cutaneous Manifestations of Diabetes Mellitus. Clin Diabetes 2015; 33(1): 40–8.
Han G. A new appraisal of dermatolog-ic manifestations of diabetes mellitus. Cutis 2014; 94(1): E21‒6.
Rosen J, Yosipovitch G. Skin Manifestations of Diabetes Melli-tus. [updated 2018 Jan 4]. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, et al, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000. Available from: http://www.ncbi.nlm.nih.gov/books/NBK481900/
Van Hattem S, Bootsma AH, Bing Thio H. Skin manifestations of diabetes. Review. Cleve Clinic Med 2008; 75(11): 772, 774, 776‒7, 780‒7.
Sreeedevi C, Car N, Pavlić-Renar I. Dermatologic lesions of dia-betes mellitus. Review. Diabetol Croat 2002; 31(3): 147‒59.
Cvitanović H, Jančić E, Knežević E, Kuljanac I. Skin changes in pa-tients with diabetes mellitus in Karlovac county. Acta Med Croat 2009; 45(4): 370‒80.
Kojić Damjanov S, Đerić M, Eremić Kojić N. Glycated hemoglo-bin A1c as a modern biochemical marker of glucose regula-tion. Med Pregl 2014; 67(9‒10): 339‒44.
Bhat YJ, Gupta V, Kudyar RP. Cutaneous manifestations of di-abetes mellitus. Int J Diabetes Dev Ctries 2006; 26: 152‒5.
Furquana N, Bashir F, Shams N, Shaikh Z, Ahmed I. Cutaneous manifestations of diabetes mellitus type 2: prevalence and as-sociation with glycemic control. J Pak Assoc Dermatol 2016; 26 (1): 4‒11.
Phulari YJ, Kaushik V. Study of cutaneous manifestations of type 2 diabetes mellitus. Int J Res Dermatol 2018; 4(1): 8‒13.
Furqan S, Kamani L, Jabbar A. Skin manifestations in diabetes mellitus. J Ayub Med Coll Abbottabad 2014; 26(1): 46‒8.
Ghos K, Das K, Ghos S, Chakraborty S, Jatua SK, Bhattacharya A, et al. Prevalence of skin changes in diabetes mellitus and its correlation with internal diseases: a single center observational study. Indian J Dermatol 2015; 60(5): 465‒9.
Foss NT, Polon DP, Takada MH, Foss-Freitas MC, Foss MC. Skin lesions in diabetic patients. Rev Saude Publica 2005; 39(4): 677‒82. (Portoguese)
Ahmed K, Muhammad Z, Qayum I. Prevalence of cutaneous manifestations of diabetes mellitus. J Ayub Med Coll Abbot-tabad 2009; 21(2): 76‒9.
Mahajan S, Koranne RV, Sharma SK. Cutaneous manifestation of diabetes mellitus. Indian J Dermatol Venereol Leprol 2003; 69(2): 105‒8.
Vahora R, Thakkar S, MarfatiaY. Skin, a mirror reflecting dia-betes mellitus: A longitudinal study in a tertiary care hospital in Gujarat. Indian J Endocr Metab 2013; 17(4): 659–64.
Chatterjee N, Chattopadhyay C, Sengupta N, Das C, Sarma N, Pal SK. An observational study of cutaneous manifestations in di-abetes mellitus in a tertiary care hospital of Eastern In-dia. Indian J Endocr Metab 2014; 18(2): 217–20.
Demirseren DD, Emre S, Akoglu G, Arpacı D, Arman A, Metin A, et al. Relationship between skin diseases and extracutane-ous complications of diabetes mellitus: clinical analysis of 750 patients. Am J Clin Dermatol 2014; 15(1): 65‒70.
Vani G, Reddy VN. A clinical study of diabetic dermatologi-cal manifestations at a tertiary care hospital in South India. Int J Res Dermatol 2018; 4(3): 293‒7.
Bhardwaj N, Roy S, Jindal R, Ahmad S. Cutaneous manifesta-tions of diabetes mellitus: a clinical study. Int J Res Dermatol 2018; 4(3): 352‒6.
Piérard GE, Seité S, Hermanns-Lê T, Delvenne P, André Scheen, Piérard-Franchimont C. The skin landscape in diabetes mellitus. Focus on dermocosmetic management. Clin Cosmet Investig Dermatol 2013; 6: 127–35.
Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiolo-gy of diabetic foot ulceration: a systematic review and meta-analysis (†). Ann Med 2017; 49(2): 106‒6.
Yosipovitch G, Hodak E, Vardi P, Shraga I, Karp M, Sprecher E, et al. The prevalence of cutaneous manifestations in IDDM patients and their association with diabetes risk factors and microvascular complications. Diabetes Care 1998; 21(4): 506‒9.
Armstrong DG, Boulton AJM, Bus SA. Diabetic Foot Ulcers and Their Recurrence. N Engl J Med 2017; 376(24): 2367‒75.
Chandrashekar SM, Suraj Muralidhar S. A study on the preva-lence of risk factors and presence of diabetic foot ulcers in T2DM patients in K. R. Hospital. Int Surg J 2017; 4(9): 2983‒6.
Hussain SM, Ahmed SI. Schamberg Purpura - A Rare Compli-cation of Skin associated with Type 2 Diabetes Mellitus. Journ Rawalp Med College (JRMC) 2014; 18(1): 163.
Sasmaz S, Buyukbese M, Cetinkaya A, Celik M, Arican O. The Prevalence of Skin Disorders in Type-2 Diabetic Patients. Int J Dermatol 2004; 3: 1.
Casagrande SS, Menke A, Cowie CC. No Association between Psoriasis and Diabetes in the U.S. Population. Diabetes Res Clin Pract 2014; 104(3): e58–60.
Dinić MŽ, Zečević RD, Hajduković Z, Mijušković M, Djurić P, Jović Z, et al. Psoriasis is the independent factor for early athero-sclerosis: A prospective study of cardiometabolic risk profile. Vojnosanit Pregl 2016; 73(12): 1094–101.
Karadag AS, Ozly E, Lavery MJ. Cutaneous manifestations of diabetes mellitus and the metabolic syndrome. Clin Dermatol 2018; 36(1): 89‒3.
Khalid U, Hansen PR, Gislason GH, Lindhardsen J, Kristensen SL, Winther SA, et al. Psoriasis and new-onset diabetes: a Danish nationwide cohort study. Diabetes Care 2013; 36(8): 2402‒7.
Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis. JAMA Dermatol 2013; 149(1): 84–91.
Maluki AH, Abdullah AA. Metabolic Associations with Skin Tags. Int J Dermatol Clin Res 2016; 2(1): 3‒11.
George MS, Walton S. Diabetic dermopathy. Br J Diabetes Vasc Dis 2014; 14(3): 95‒7.
Morgan AJ, Schwartz RA. Diabetic dermopathy: A subtle sign with grave implications. J Am Acad Dermatol 2008; 58(3): 447‒51.
Babakinejad P, Walton S. Diabetes and pruritus. Br J Diabetes 2016; 16: 154‒5.
George MS, Walton S. Granuloma annulare. Br J Diabetes 2016; 16: 58‒61.
Nobari NN, Ghalamkarpour F, Gheisari M, Iranmanesh B. Mul-tiple granuloma annulare as presenting sign of asymptomatic diabetes mellitus in a child. J Dermatol Dis 2018; 5: 274.
Cheng YW, Tsai WC, Chuang FC, Chern E, Lee CH, Sung CH et al. A retrospective analysis of 44 patients with granuloma annulare during an 11-year period from a tertiary medical cen-ter in south Taiwan. Dermatol Sin 2016; 34(3): 121‒5.
Nebesio CL, Lewia C, Chuang TZ. Lack association between granuloma annulare and type 2 diabetes mellitus. Br J Derma-tol 2002; 146(1): 122‒4.
Draznin M, Eison R, Maverakis E, Huntley A. Cutaneus mani-festations of diabetes mellitus. In: Bowker J, Pfeifer M, editor. Levin and O'Neal's The Diabetic Foot with CD-ROM. 7th ed. Mosby 2008. P. 185‒97.
Shrestha B, Sharma E, Mukhtar O, Kaler J, Thapa S, Khalid M. Scleredema Diabeticorum with Superimposed Cellulitis and Abscess Formation. Case Rep Endocrinol 2018: 2018: 9513768.
Del Rosso JQ. A Closer Look at Seborrheic Keratoses: Patient Perspectives, Clinical Relevance, Medical Necessity, and Im-plications for Management. J Clin Aesthet Dermatol 2017; 10(3): 16–25.
Mettang T, Vonend A, Raap U. Prurigo nodularis: its associa-tion with dermatoses and systemic disorders. Hautarzt 2014; 65(8): 697‒703. (German)
Sundarsen S, Migden MR, Silapunt S. Stasis dermatitis: Patho-pysiology, Evaluation and Management. Am J Clin Dermatol 2017; 18(3): 389‒90.